Cargando…

Cardiac allograft vasculopathy and donor age affecting permanent pacemaker implantation after heart transplantation

AIMS: The need for permanent pacemakers (PMs) after heart transplantation (HT) is increasing. The aim was to determine the influence of cardiac allograft vasculopathy (CAV), donor age, and other risk factors on PM implantations early and late after HT and its effect on survival. METHODS AND RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roest, Stefan, Manintveld, Olivier C., Kolff, Marit A.E., Akca, Ferdi, Veenis, Jesse F., Constantinescu, Alina A., Brugts, Jasper J., Birim, Ozcan, van Osch‐Gevers, Lennie M., Szili‐Torok, Tamas, Caliskan, Kadir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934965/ https://www.ncbi.nlm.nih.gov/pubmed/35174653 http://dx.doi.org/10.1002/ehf2.13799

Ejemplares similares

Theophylline Use to Prevent Permanent Pacing in the Contemporary Era of Heart Transplantation: The Rotterdam Experience
por: Kooij, Claudette, et al.
Publicado: (2022)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis
por: Klimczak-Tomaniak, Dominika, et al.
Publicado: (2019)

Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients
por: Nous, Fay M. A., et al.
Publicado: (2021)

Epicardial fat volume is related to the degree of cardiac allograft vasculopathy
por: Roest, Stefan, et al.
Publicado: (2022)

Aortic root thrombus after left ventricular assist device implantation and aortic valve replacement
por: Veenis, Jesse F., et al.
Publicado: (2020)

Pulmonary artery pressure telemonitoring by CardioMEMS in a patient pre- and post-left ventricular assist device implantation
por: Veenis, Jesse F, et al.
Publicado: (2019)

Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II
por: Akin, S., et al.
Publicado: (2015)

Influence of renal insufficiency pre‐heart transplantation on malignancy risk post‐heart transplantation
por: Roest, Stefan, et al.
Publicado: (2021)

Survival following a concomitant aortic valve procedure during left ventricular assist device surgery: an ISHLT Mechanically Assisted Circulatory Support (IMACS) Registry analysis
por: Veenis, Jesse F., et al.
Publicado: (2020)

Preoperative right heart hemodynamics predict postoperative acute kidney injury after heart transplantation
por: Guven, Goksel, et al.
Publicado: (2018)

Design and rationale of haemodynamic guidance with CardioMEMS in patients with a left ventricular assist device: the HEMO‐VAD pilot study
por: Veenis, Jesse F., et al.
Publicado: (2019)

Safety and efficacy of the remote magnetic navigation for ablation of ventricular tachycardias—a systematic review
por: Akca, Ferdi, et al.
Publicado: (2011)

Reply to ‘Aortic valve surgery and left ventricular assist device: lights and shadows’
por: Veenis, Jesse F., et al.
Publicado: (2021)

Monitoring pulmonary pressures during long‐term continuous‐flow left ventricular assist device and fixed pulmonary hypertension: redefining alleged pathophysiological mechanisms?
por: De Bakker, Chantal C., et al.
Publicado: (2020)

Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices
por: Yalcin, Yunus C, et al.
Publicado: (2020)

(18)F-FDG PET/CT in the Diagnosis and Management of Continuous Flow Left Ventricular Assist Device Infections: A Case Series and Review of the Literature
por: Akin, Sakir, et al.
Publicado: (2018)

Single-Center Experience With Protocolized Treatment of Left Ventricular Assist Device Infections
por: Verkaik, Nelianne J., et al.
Publicado: (2022)

COVID-19-related myocarditis post-heart transplantation
por: Roest, Stefan, et al.
Publicado: (2021)

Left ventricular remodelling and prognosis after discharge in new‐onset acute heart failure with reduced ejection fraction
por: van den Berge, Jan C., et al.
Publicado: (2021)

Subacute right ventricular pacemaker lead perforation: evaluation by echocardiography and cardiac CT
por: Boxma, Reinier P. J., et al.
Publicado: (2017)

Incidence of end‐stage renal disease after heart transplantation and effect of its treatment on survival
por: Roest, Stefan, et al.
Publicado: (2020)

Safety and feasibility of hemodynamic pulmonary artery pressure monitoring using the CardioMEMS device in LVAD management
por: Veenis, Jesse F., et al.
Publicado: (2021)

First direct human evidence of a probable implantable cardioverter-defibrillator lead-related scar serving as a substrate for ventricular tachycardia
por: Abraham, Pal, et al.
Publicado: (2015)

The Dutch national paediatric heart transplantation programme: outcomes during a 23-year period
por: Roest, Stefan, et al.
Publicado: (2022)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Unusual embolization of a pacemaker lead fragment during lead extraction
por: Yap, Sing-Chien, et al.
Publicado: (2015)

Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
por: Aggarwal, Ashim, et al.
Publicado: (2012)

Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014)

Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

The role of everolimus in treatment of cardiac allograft vasculopathy
por: Watanabe, Tetsu
Publicado: (2013)

The novel proteomic signature for cardiac allograft vasculopathy
por: Wei, Dongmei, et al.
Publicado: (2022)

Bradyarrhythmia development and permanent pacemaker implantation after cardiac surgery
por: Turkkan, Ceyhan, et al.
Publicado: (2018)

Early rapidly developing constrictive pericarditis after aortic valve surgery
por: Brugts, J. J., et al.
Publicado: (2014)

Transhepatic echocardiography: a novel approach for imaging in left ventricle assist device patients with difficult acoustic windows
por: Strachinaru, Mihai, et al.
Publicado: (2020)

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
por: Kobashigawa, Jon
Publicado: (2000)

Correction to: Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
por: Ellimuttil, Tracey M, et al.
Publicado: (2021)

Reasons for Delay in Permanent Pacemaker Insertion
por: Mackintosh, A F, et al.
Publicado: (1986)

Evaluation of patients with a HeartMate 3 left ventricular assist device using echocardiographic particle image velocimetry
por: Schinkel, Arend F. L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0p2p2ltv1lep1io8an74kn3avi